Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 3
Incremental prognostic value of regurgitant fraction in patients with ventricular secondary mitral regurgitation
Jana Ambrožič, Jana Ambrožič, Dušica Prodanova, Ana Starc, Mojca Škafar, Ljupka Dimitrovska, Janez Toplišek, Mojca Bervar, Matjaž Bunc, Marta Cvijić
Izvirni znanstveni članek
Oznake: mitral regurgitation;quantification;PISA method;regurgitant fraction;outcome;
Objectives: Quantifying ventricular secondary mitral regurgitation (MR) remains challenging, and the prognostic value of echocardiographic parameters is uncertain. This study aimed to assess the concordance of parameters of MR severity and determine the added value of regurgitant fraction (RF) in pr ...
Leto: 2026 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
ǂA ǂcomparison of transcatheter aortic valve prosthesis platforms
Matjaž Bunc, Klemen Steblovnik, Simon Terseglav, Jana Ambrožič, Mojca Bervar, Ljupka Dimitrovska, Miha Čerček, Ana Kovač, Patricija Mohorko-Pleskovič, Polonca Kogoj, Zlatko Fras, Miha Šušteršič, Bojan Vrtovec
Izvirni znanstveni članek
Oznake: transcatheter aortic valve implantation;aortic stenosis;real-world comparison;
Background This article compares the real-world performance and safety of the three transcatheter aortic valve implantation (TAVI) platforms: Myval, Sapien, and Evolut in patients with severe symptomatic aortic stenosis and low to moderate surgical risk. Patients and methods Between September 2019 a ...
Leto: 2025 Vir: Onkološki inštitut Ljubljana (OI)
1-year outcomes of novel balloon-expandable vs contemporary transcatheterheart valves in severe aortic stenosis
Patrick W. Serruys, Akihiro Tobe, Niels Van Royen, Ignacio J. Amat-Santos, Martin Hudec, Matjaž Bunc, Ben J. L. Van den Branden, Peep Laanmets, Daniel Unic, Bela Merkely, Simon Terseglav, Klemen Steblovnik, Miha Čerček, Luka Vitez, Miha Šušteršič, Ana Kovač, Polonca Kogoj, Ljupka Dimitrovska
Izvirni znanstveni članek
Oznake: Evolut;Myval;SAPIEN;randomizirano kontrolirana raziskava;perkutana zamenjava aortne zaklopke;randomized controlled trial;transcatheter aortic valve replacement;
Background In the LANDMARK trial, the Myval balloon-expandable transcatheter heart valve (THV) series was noninferior to the most commonly used contemporary SAPIEN and Evolut Series THVs for the 30-day early safety endpoint in participants with symptomatic severe native aortic stenosis. Objectives T ...
Leto: 2026 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Št. zadetkov: 3
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: